Posters

Always at the forefront of the dynamic patient-derived xenograft (PDX) market, Champions Oncology has emerged as a respected key opinion leader on the utilization and benefits of PDX models in oncology drug development.

AACR 2020: Natural Killer (NK) Human immune system (HIS) ImmunoGraft Platform to Evaluate the Pharmacodynamics of Immuno-Oncology Therapeutics

Download Poster

AACR 2020: 2D Ex vivo patient derived acute myeloid leukemia platform for evaluation of novel molecular targeted therapeutic agents

Download Poster

AACR 2019 - Establishment of a patient-derived acute myeloid leukemia (AML) ex vivo platform for evaluation of novel therapeutic agents

Download Poster

NYAS 2019 - Unique Immunodeficient Murine Host Strains Impact Expansion and Engraftment of T Cells in PBMC Humanized Mice

Download Poster

EORTC 2018 - Establishment of ImmunoGraft® with human immune system(HIS) and PDX co-engraftment using NOG-EXL mice to evaluate checkpoint inhibitors

Download Poster

EORTC 2018 - Patient-derived xenograft (PDX) models from metastatic castration-resistant prostate cancer (mCRPC) patients reflect clinical disease and therapeutic outcomes

Download Poster

SITC 2018 - Autologous human immune system (HIS) ImmunoGraft®: Mobilized peripheral blood (MPB) derived CD34 engraftment and lineage development

Download Poster

SITC 2018 - Haplotype human immune system (HIS) modeling and co-engraftment of PDX: ImmunoGraft® platform for evaluation of pharmacodynamics of Immuno Oncology therapeutics

Download Poster

AACR 2018 - Inflammatory and stem-like colorectal cancer (CRC) subtypes identified in patient-derived xenograft (PDX) models show tumor growth inhibition (TGI) by the combination of trametinib (T) and neratinib (N) irrespective of KRAS mutation (MT) status

Download Poster

EORTC 2017 - Patient-derived xenograft (PDX) models of NSCLC reflect clinical drug responses and predict effective treatments for patients

Download Poster

AACR 2017 - Patient-derived xenografts effectively capture patient clinical responses to oncology therapy

Download Poster